Advertisement

Topics

Namaste Technologies Inc awaiting sales license as plans to up-list on the Nasdaq

10:38 EDT 14 Sep 2018 | Proactive Investors

Namaste Technologies Inc (CVE:N, OTCQB:NXTTF) CEO Sean Dollinger tells Proactive Investors the cannabis e-commerce company's plan to up-list to the Nasdaq is pushing along.

Dollinger says the company is awaiting its sales license to sell cannabis online, which he says should come anytime now. He believes this will be the catalyst to move the company to US$4 per share, the minimum share price to list on a major exchange.

After recording the interview, Dollinger reacted to Andrew Left's comment from Citron Research calling Namaste's shares 'joke.' Dollinger fired back at Left saying, "we’ll prove to him that he’s the joke.”

Original Article: Namaste Technologies Inc awaiting sales license as plans to up-list on the Nasdaq

NEXT ARTICLE

More From BioPortfolio on "Namaste Technologies Inc awaiting sales license as plans to up-list on the Nasdaq"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...